Scrip
Novavax shares slide on cash injection
25 November 2009
Christopher Spillane
Please Login to read the full article.
25 November 2009
Christopher Spillane
Novavax's share price has tumbled by more than 15% in the days following the pricing of its public offering.
The vaccine developer raised net proceeds of around $21 million to fund preclinical and clinical trials of its virus-like-particle (VLP) technology as well as other research programmes...
Please Login to read the full article.
RELATED CONTENT
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
